The Human Advantage Stronger Brains in the Age of AI 2026
Page 8 of 33 · WEF_The_Human_Advantage_Stronger_Brains_in_the_Age_of_AI_2026.pdf
Behind the data: Women’s brain health BOX 2
Certain brain-related conditions – including
depression, anxiety, dementias and migraines –
disproportionately affect women. For example,
two-thirds of people living with Alzheimer’s disease
globally are women.16 Many of the conditions
that shorten women’s healthspan (for example,
endometriosis) or lifespan (for example, breast
cancer) also have close links with mental health
challenges, compounding the overall burden.
Even natural biological transitions can introduce
brain health challenges. During menopause, the
precipitous decline of oestrogen can increase the
risk of cognitive decline, a symptom associated with mild cognitive impairment and dementia.17
Research is still nascent in many areas of women’s
brain health, with the first comprehensive mapping
of the maternal brain from preconception through
the post-partum period only published in 2024.18
Mental and neurological disorders account for
nearly 25% of the $1 trillion GDP gains that
could be realized annually by 2040 by closing the
women’s health gap.19 Incorporating sex-based
approaches in care and intervention can address
gaps in efficacy, adoption and uptake that could
affect both men and women.
Support promotion of healthy brain function and prevention
of brain health conditions across the life course1
Brain health is shaped across the life course.
From conception onwards, multiple windows
of vulnerability and opportunity determine brain
development, function and resilience. Yet many
health systems are designed to treat acute
symptoms in adulthood, missing opportunities to
strengthen brain health earlier and more effectively.
Proactive age- and sex-appropriate interventions
can protect brain health before problems arise.
For example, access to quality prenatal and
perinatal care promotes healthy brain development
before birth.20 In early childhood, ensuring
adequate nutrition,21 reducing toxic stress22 and
providing timely screening23 can improve a child’s
neurodevelopment.24 Proactive interventions are
also critical later in life. About 85% of the global
health impact of stroke is causally linked to one or
more of 23 modifiable risk factors that include high
blood pressure, air pollution, unhealthy diets, lack of physical activity and alcohol use.25 For brain health
in older adults, the US POINTER study highlights
the benefits of combined lifestyle interventions, such
as neuroprotective diets, exercise and cognitive
training.26 These interventions also drive healthy
longevity, reinforcing the links between brain health,
metabolic health and cardiovascular resilience.27
Early detection also plays a critical role. Cognitive
and behavioural assessment tools, with emerging
evidence around digital and biological biomarkers,
can establish a baseline and identify issues early,
supporting behavioural changes or early intervention
when needed.28
Promoting brain health across the life course, within
and beyond health systems, is essential to building
population-level brain capital and reducing the
compounding effects of untreated conditions.
Scale access to evidence-based treatment and services
for brain health conditions
While many brain health conditions may not have a
known cure, they are treatable. Scaling access to
proven brain health interventions could reduce the
global burden of disease by more than 260 million
DALYs – a measure that captures both years lost to
early death and years lived with illness or disability.29
This could result in up to $6.2 trillion in cumulative
GDP gains, with more people able to live fully,
contribute meaningfully and sustain their roles as
parents, partners and community members.30
Timely access to effective care matters across
the life course. For example, a child who is
neurodivergent needs timely support to learn and
thrive; a mother experiencing depression needs care to regain stability for herself and her child;
and an older adult facing dementia deserves
early identification and respectful care. Treatment
gaps remain widespread across all settings and
are particularly stark in low- and middle-income
countries (LMICs), where more than 75% of people
with MNS disorders go without access to adequate
services and support.31 When care is available, it is
often fragmented, outdated or not adapted to the
cultural and practical realities of local communities.
Without consistent quality, patients are less likely to
improve, and governments and health systems lose
the opportunity to achieve meaningful returns on
their investments.2
The Human Advantage: Stronger Brains in the Age of AI
8
Ask AI what this page says about a topic: